Johnson & Johnson stands to turn a pandemic into a payday at the expense of taxpayers.
Upon closer look, J&J stands to profit handsomely.
"The price hike coincides with the company's push to get its drug to more patients — specifically those diagnosed with COVID-19."
Drug companies only showed interest in COVID-19 vaccines and treatments when huge profits arose.
The federal government will be the single largest investor and the largest purchaser of an upcoming COVID-19 vaccine or treatment.
In just one week, U.S. taxpayers gave more than $700 million to pharma for COVID-19 research and development.
Patients For Affordable Drugs and 63 people living with diabetes penned a letter to the Big 3 insulin manufacturers urging them to take action to lower the list prices of their insulin products immediately.